Target Name: MMD
NCBI ID: G23531
Review Report on MMD Target / Biomarker Content of Review Report on MMD Target / Biomarker
MMD
Other Name(s): macrophage maturation-associated | Monocyte to macrophage differentiation factor | Monocyte to macrophage differentiation protein | Monocyte to macrophage differentiation-associated | progestin and adipoQ receptor family member 11 | Progestin and adipoQ receptor family member XI | MMA | monocyte to macrophage differentiation protein | Progestin and adipoQ receptor family member 11 | progestin and adipoQ receptor family member XI | PAQRB_HUMAN | Monocyte to macrophage differentiation associated | PAQR11 | MMD1 | Macrophage maturation-associated | monocyte to macrophage differentiation associated

MMMA: A Protein Involved in Macrophage Function and Disease

Macrophage maturation-associated (MMMA) is a protein that is expressed in macrophages, which are a type of white blood cell that play a crucial role in fighting off infections and diseases. MMMAs are associated with the maturation and functionalization of macrophages, and they have been identified as potential drug targets or biomarkers for a variety of diseases.

One of the key functions of macrophages is their ability to phagocytose, or engulf and destroy foreign particles such as bacteria, viruses, and dead cells. This process is critical for maintaining the overall health and wellbeing of the body. MMMAs are involved in the phagocytosis process by helping to form the phagosome, a structure that surrounds and engulfs the invading particle.

MMMA is also involved in the regulation of inflammation and immune responses. When the body is exposed to an infection or injury, macrophages are activated and begin to produce MMMAs. These MMMAs help to facilitate the phagocytosis of the invading particle and also participate in the production of inflammatory cytokines, which are important for the immune response.

In addition to their role in immune function, MMMAs are also potential drug targets for a variety of diseases. For example, MMMAs have been identified as potential targets for cancer, as they have been shown to contribute to the development and progression of many types of cancer. In addition, MMMAs have also been shown to be involved in a variety of neurological and psychiatric diseases, including Alzheimer's disease, Parkinson's disease, and depression.

One of the challenges in studying MMMAs as potential drug targets is their complex structure and function. MMMAs are produced by a variety of cell types, including macrophages, and can have different forms and functions depending on the cell type and context. Additionally, MMMAs can be expressed in different tissues and organs, which can make it difficult to study their effects in a specific context.

However, researchers are making progress in understanding the role of MMMAs in disease and are identifying potential drug targets. For example, studies have shown that inhibiting the activity of MMMAs can be effective in treating a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. In addition, researchers have also identified MMMAs as potential biomarkers for a variety of diseases, which could be used to monitor the effectiveness of different treatments.

Overall, MMMAs are a complex and multifaceted protein that are involved in a variety of immune and physiological processes. While more research is needed to fully understand the role of MMMAs in disease, they are an promising area of study and may provide new insights into the underlying mechanisms of many diseases.

Protein Name: Monocyte To Macrophage Differentiation Associated

Functions: Involved in the dynamics of lysosomal membranes associated with microglial activation following brain lesion

The "MMD Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MMD comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MMD2 | MME | MMEL1 | MMGT1 | MMP | MMP1 | MMP10 | MMP11 | MMP12 | MMP13 | MMP14 | MMP15 | MMP16 | MMP17 | MMP19 | MMP2 | MMP2-AS1 | MMP20 | MMP20-AS1 | MMP21 | MMP23A | MMP23B | MMP24 | MMP24-AS1-EDEM2 | MMP24OS | MMP25 | MMP25-AS1 | MMP26 | MMP27 | MMP28 | MMP3 | MMP7 | MMP8 | MMP9 | MMRN1 | MMRN2 | MMS19 | MMS22L | MMS22L-TONSL complex | MMUT | MMXD complex | MN1 | MNAT1 | MND1 | MNDA | MNS1 | MNT | MNX1 | MNX1-AS1 | MOAP1 | MOB1A | MOB1B | MOB2 | MOB3A | MOB3B | MOB3C | MOB4 | MOBP | MOCOS | MOCS1 | MOCS2 | MOCS2-DT | MOCS3 | MOG | MOGAT1 | MOGAT2 | MOGAT3 | MOGS | MOK | MON1A | MON1B | MON2 | Monoamine oxidase (MAO) | Monoamine Transporter (MAT) | MORC1 | MORC2 | MORC2-AS1 | MORC3 | MORC4 | MORF4 | MORF4L1 | MORF4L1P1 | MORF4L1P3 | MORF4L1P7 | MORF4L2 | MORF4L2-AS1 | MORN1 | MORN2 | MORN3 | MORN4 | MORN5 | MOS | MOSMO | MOSPD1 | MOSPD2 | MOSPD3 | MOV10 | MOV10L1 | MOXD1 | MOXD2P